Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 13,858 | 16,146 | 0 | 0 | 0 |
| Cost of Goods | 2,388 | 475 | N/A | N/A | N/A |
| Gross Profit | 11,470 | 15,671 | N/A | N/A | N/A |
| Operating Expenses | 96,278 | 105,606 | 82,196 | 123,481 | 69,717 |
| Operating Income | -84,420 | -89,460 | -82,196 | -123,481 | -69,717 |
| Other Income | 6,185 | 9,965 | 8,406 | 2,764 | -6,258 |
| Pre-tax Income | -78,235 | -79,495 | -73,790 | -120,717 | -75,975 |
| Income Tax | 1,386 | -2,164 | 0 | N/A | N/A |
| Net Income Continuous | -79,621 | -77,331 | -73,790 | -120,717 | -75,975 |
| Net Income | $-79,621 | $-77,331 | $-73,790 | $-120,717 | $-75,975 |
| EPS Basic Total Ops | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 |
| EPS Basic Continuous Ops | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 |
| EPS Diluted Total Ops | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 |
| EPS Diluted Continuous Ops | -1.28 | -1.32 | -1.85 | -3.65 | -8.95 |
| EPS Diluted Before Non-Recurring Items | -1.28 | -1.04 | -1.85 | -3.65 | -8.95 |
| EBITDA(a) | $-82,869 | $-92,587 | $-85,057 | $-122,772 | $-69,070 |